Kabra Drugs has informed that it enclosed a copy of the Certificate dated April 5, 2022 received from Skyline Financial Services, the Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2022.
The above information is a part of company’s filings submitted to BSE.